Abbott Laboratories
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical De…
Medical - Devices
US, North Chicago [HQ]
Insiders
Transactions
Track non-derivative insider transactions.
i = Indirect Ownership
d = Direct Ownership
cs = Common Stock
| Reported Owner(s) | Position Now | Transaction Date | Type | Position Change | Extra | ||
|---|---|---|---|---|---|---|---|
|
$342,227
d
Common shares without par value
10% Holder
|
10/21/24 |
M
|
157,421 x $47.00 = $7,398,787.00 |
Footnotes
#1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $118.68 to $118.92, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
#2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.68 to $118.59, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
#3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.68 to $117.64, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
|
|||
|
$335,077
d
Common shares without par value
10% Holder
|
10/21/24 |
S
|
5,901 x $118.15 = $697,203.15 |
Footnotes
#1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $118.68 to $118.92, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
#2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.68 to $118.59, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
#3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.68 to $117.64, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
|
|||
|
$184,806
d
Common shares without par value
10% Holder
|
10/21/24 |
S
|
150,271 x $116.98 = $17,578,701.58 |
Footnotes
#1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $118.68 to $118.92, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
#2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.68 to $118.59, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
#3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.68 to $117.64, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
|
|||
|
$340,978
d
Common shares without par value
10% Holder
|
10/21/24 |
S
|
1,249 x $118.81 = $148,393.69 |
Footnotes
#1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $118.68 to $118.92, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
#2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.68 to $118.59, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
#3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.68 to $117.64, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
|
|||
|
$347,495
d
Common shares without par value
10% Holder
|
09/12/24 |
M
|
127,436 x $47.00 = $5,989,492.00 |
Footnotes
#1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.58 to $116.54, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
#2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.58 to $117.29, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
|
|||
Get PRO Today
With PRO you will unlock 54 more insider transactions for Abbott Laboratories
Statistics
Sample Size: 59 Transactions
Sale (S)
391,535 Shares
28.81%
Buy (P)
0 Shares
0.00%
Individuals
We summarize earnings call passages, compensations, insider transactions and other information for each individual to get the bigger picture:
- Allen Hubert L EXECUTIVE VICE PRESIDENT
- Alpern Robert J Director
- Babineaux-Fontenot Claire Director
- Blount Sally E. Director
- Boudreau Philip P EXECUTIVE VICE PRESIDENT
- Earnhardt Lisa D EXECUTIVE VICE PRESIDENT
- Ford Robert B CHAIRMAN AND CEO
- Funck, Jr. Robert E. EXECUTIVE VICE PRESIDENT
- Gonzalez Patricia Paola Director
- Kumbier Michelle Director
- Mccoy John A. Jr. VICE PRESIDENT
- Mcdew Darren W Director
- Mckinstry Nancy Director
- Moreland Mary K EXECUTIVE VICE PRESIDENT
- Morrone Louis H. EXECUTIVE VICE PRESIDENT
- O'Grady Michael Director
- Roman Michael F Director
- Salvadori Daniel Gesua Sive EXECUTIVE VICE PRESIDENT
- Starks Daniel J Director
- Stratton John G Director
- Wainer Andrea F EXECUTIVE VICE PRESIDENT
Individuals
We summarize earnings call passages, compensations, insider transactions and other information for each individual to get the bigger picture:
- Allen Hubert L EXECUTIVE VICE PRESIDENT
- Alpern Robert J Director
- Babineaux-Fontenot Claire Director
- Blount Sally E. Director
- Boudreau Philip P EXECUTIVE VICE PRESIDENT
- Earnhardt Lisa D EXECUTIVE VICE PRESIDENT
- Ford Robert B CHAIRMAN AND CEO
- Funck, Jr. Robert E. EXECUTIVE VICE PRESIDENT
- Gonzalez Patricia Paola Director
- Kumbier Michelle Director
- Mccoy John A. Jr. VICE PRESIDENT
- Mcdew Darren W Director
- Mckinstry Nancy Director
- Moreland Mary K EXECUTIVE VICE PRESIDENT
- Morrone Louis H. EXECUTIVE VICE PRESIDENT
- O'Grady Michael Director
- Roman Michael F Director
- Salvadori Daniel Gesua Sive EXECUTIVE VICE PRESIDENT
- Starks Daniel J Director
- Stratton John G Director
- Wainer Andrea F EXECUTIVE VICE PRESIDENT